Autonomous AI-based system compliant with expert consensus for the treatment of AMD
New findings suggest the potential of a new artificial intelligence-based system for autonomous monitoring of patients treated for neovascular age-related macular degeneration (nAMD). Research has demonstrated both its safety and compliance with expert consensus as being on par with decisions made in clinical practice, with particularly low rates of false positive classification of choroidal neovascularization …
Autonomous AI-based system compliant with expert consensus for the treatment of AMD Read More »